| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2002 | US6419676 Spine distraction implant and method |
| 07/16/2002 | CA2367186A1 Method for preventing and treating skin aging |
| 07/16/2002 | CA2268773C Skin battery cosmetic composition |
| 07/16/2002 | CA2240846C Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/16/2002 | CA2236158C Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/16/2002 | CA2233632C Phosphorus containing cythesine derivatives |
| 07/16/2002 | CA2214097C Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
| 07/16/2002 | CA2206172C New derivatives of 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/16/2002 | CA2205998C Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 07/16/2002 | CA2197702C Use of a 2-amino-alkane-1,3-diol to slow loss of hair and/or stimulate or induce hair growth |
| 07/16/2002 | CA2171738C Parenteral busulfan for treatment of malignant disease |
| 07/16/2002 | CA2165521C Topical composition containing a p substance antagonist |
| 07/16/2002 | CA2165519C P substance antagonist used for the treatment of itching, ocular and/or palpebral algia and ocular and/or palpebral dysesthesia |
| 07/16/2002 | CA2165518C P substance antagonist used for the treatment of neurogenous skin redness |
| 07/16/2002 | CA2159730C Ionene polymers as anthelmintics in animals |
| 07/16/2002 | CA2131383C Wound healing and treatment of fibrotic disorders |
| 07/16/2002 | CA2125666C Medicaments |
| 07/16/2002 | CA2119511C Benzimidazole compounds, their use and preparation |
| 07/16/2002 | CA2116956C Pharmaceutical process |
| 07/16/2002 | CA2105977C Thiocarbamate sulfoxide composition for deterring ethanol ingestion |
| 07/16/2002 | CA2104452C Treatment of cellulite with retinoids |
| 07/16/2002 | CA2063594C 5-(1-aminocyclohexyl)-2(1h)-pyridinone and related compounds |
| 07/16/2002 | CA2059704C [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives |
| 07/16/2002 | CA2052392C Extract from ginkgo biloba leaves, in particular for intravenous injection or infusion, a method of preparation of the extract and ampoule preparations containing the extract |
| 07/16/2002 | CA2050875C 3-(1h-indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments |
| 07/16/2002 | CA2034128C Rapid miosis with control of intraocular pressure |
| 07/11/2002 | WO2002088120A1 Method for obtaining pioglitazone as an antidiabetic agent |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053700A2 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/11/2002 | WO2002053617A1 Linear block polymer |
| 07/11/2002 | WO2002053573A1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053564A2 Quinuclidine derivatives and their use as m3 antagonists |
| 07/11/2002 | WO2002053561A1 Excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053559A1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053555A2 Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053550A1 Benzofuran derivatives and pharmaceutical compositions containing the same |
| 07/11/2002 | WO2002053546A1 Heterocycle derivatives as ppar-gamma agonists |
| 07/11/2002 | WO2002053542A1 Process for making amlodipine maleate |
| 07/11/2002 | WO2002053541A1 Amide derivative of amlodipine |
| 07/11/2002 | WO2002053539A1 Amlodipine hemimaleate |
| 07/11/2002 | WO2002053538A1 Amlodipine fumarate |
| 07/11/2002 | WO2002053535A2 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 07/11/2002 | WO2002053533A2 Kappa opioid receptor ligands |
| 07/11/2002 | WO2002053530A1 Method for concentrating and stabilising carotenoids from vegetables or fruits |
| 07/11/2002 | WO2002053528A1 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | WO2002053525A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053516A2 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
| 07/11/2002 | WO2002053190A2 Particles for inhalation having sustained release properties |
| 07/11/2002 | WO2002053188A1 Compositions comprising cyclodextrins and no-releasing drugs |
| 07/11/2002 | WO2002053187A2 Methods and transdermal compositions for pain relief |
| 07/11/2002 | WO2002053186A2 Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus |
| 07/11/2002 | WO2002053185A2 Anti-inflammatory use of polycationic compounds |
| 07/11/2002 | WO2002053177A2 Agents and methods for treating pain |
| 07/11/2002 | WO2002053171A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 07/11/2002 | WO2002053169A2 Use of dipeptylpeptidase iv and aminopeptidase-n inhibitors in the treatment of ischaemia-induced neuro-degeneration |
| 07/11/2002 | WO2002053164A1 Drynaria extractions for treating osteoporosis and their extraction process |
| 07/11/2002 | WO2002053162A1 Method for treating glaucoma iiib |
| 07/11/2002 | WO2002053161A1 Method for treating fibrotic diseases or other indications |
| 07/11/2002 | WO2002053160A1 Method for treating glaucoma ivb |
| 07/11/2002 | WO2002053159A1 Neurotrophic tacrolimus analogs |
| 07/11/2002 | WO2002053158A1 Method for treating glaucoma ib |
| 07/11/2002 | WO2002053156A1 Method for treating glaucoma ii b |
| 07/11/2002 | WO2002053155A1 Telomerase inhibitor |
| 07/11/2002 | WO2002053154A1 Pharmaceutical emulsion preparation |
| 07/11/2002 | WO2002053153A1 Medicines for treatment and prevention of neurogenic pain |
| 07/11/2002 | WO2002053152A1 Composition containing flavonoids for treatment brain disorders |
| 07/11/2002 | WO2002053151A1 Perfume compositions |
| 07/11/2002 | WO2002053150A1 Preventives for wound adhesion |
| 07/11/2002 | WO2002053149A2 Medicament containing a polyamine as an active substance |
| 07/11/2002 | WO2002053148A1 Ubiquinone derivatives containing dental care agents |
| 07/11/2002 | WO2002053147A1 Pharmaceutical composition for the treatment of cerebrovascular cognitive disease |
| 07/11/2002 | WO2002053146A2 Matrix metalloproteinase inhibitors |
| 07/11/2002 | WO2002053145A1 Use of polidocanol for the treatment of the uterine and the fallopian tubes |
| 07/11/2002 | WO2002053144A1 Regulation of organic nitrate tolerance |
| 07/11/2002 | WO2002053143A2 Treatment of erectile dysfunction with rho-kinase inhibitors |
| 07/11/2002 | WO2002053142A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 07/11/2002 | WO2002053141A2 Inhibition of angiogenesis by nucleic acids |
| 07/11/2002 | WO2002053140A2 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | WO2002053139A2 Excitatory amino acid receptor antagonist and 5-ht1f agonist combination: a method for the treatment of neurological disorders |
| 07/11/2002 | WO2002053138A2 Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| 07/11/2002 | WO2002053137A2 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 07/11/2002 | WO2002053135A1 Amlodipine free base |
| 07/11/2002 | WO2002053134A1 Pharmaceutical compositions comprising amlodipine maleate |
| 07/11/2002 | WO2002053133A1 Pharmaceutical composition containing citalopram |
| 07/11/2002 | WO2002053132A1 Water-soluble powdery or granular compositions based on phenanthridines and their uses |
| 07/11/2002 | WO2002053129A1 Sustained release drug delivery devices with prefabricated permeable plugs |
| 07/11/2002 | WO2002053127A1 Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
| 07/11/2002 | WO2002053125A2 Skin care product containing a retinoid and a retinoid booster system in a dual compartment package |
| 07/11/2002 | WO2002053122A2 Skin care product containing retinoids and phytoestrogens in a dual compartment package |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2002053108A2 Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package |
| 07/11/2002 | WO2002053104A2 Use of catecholamine reuptake inhibitors to enhance memory |